Digitalis use in children: An uncertain future

Progress in Pediatric Cardiology

Volumn 12, Issue 1, 2000, Pages 37-43

  Hougen, Thomas J ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiac glycosides; Congestive heart failure; Digoxin like immunoreactive substances; NaK ATPase; Sodium pump; Toxicity

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CARDIAC GLYCOSIDE; DIGITALIS; DIGITALIS LIKE FACTOR; DIGOXIN; DIGOXIN ANTIBODY F(AB) FRAGMENT;

ADULTHOOD; AGE; CATION TRANSPORT; CHILDHOOD; CONGESTIVE HEART FAILURE; DIGITALIS INTOXICATION; DRUG INDICATION; DRUG MECHANISM; DRUG USE; HEART AFTERLOAD; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT RIGHT SHUNT; HEART OUTPUT; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK; SPECIES DIFFERENCE;

EID: 0033658262     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1058-9813(00)00057-6     Document Type: Article

References (81)

1. An account of the foxglove, and some of its medical uses, with practical remarks on dropsy, and other diseases
2. The foxglove, 'the old woman from Shropshire', and William Withering
3. Pharmacotherapy for systolic dysfunction: a review of randomized clinical trials
4. Digitalis
5. Cardiac glycosides in the next millennium
6. Use of digoxin in the young
7. Herzglykoside als Hemmstoffe fur den aktiven Kalium und Natriumtransport durch die Erythroctenmembran
8. The influence of some cations on an adenosine triphosphatase from peripheral nerves
9. + across the nerve membrane
10. Digitalis: mechanisms of action and clinical use
11. The energy coupled exchange of Na for K across the cell membrane. The NaK-pump
12. NaK-ATPase
13. Influence of isoproterenol and ouabain on excitation-contraction coupling, cross-bridge function, and energetics in failing human myocardium
14. Molecular genetics of NaK-ATPase
15. Isozymes of the NaK-ATPase heterogeneity in structure, diversity, and function
16. Hormonal regulation of the NaK-ATPase mechanisms underlined rapid and sustained changes in pump activity
17. Identification of the mammalian NaK-ATPase beta 3 sub-unit
18. Expression of alpha isoforms of the NaK-ATPase in the human heart
19. Sequence analysis of DNA encoding an avian NaK-ATPase beta 2-sub-unit
20. Stability of the NaK-ATPase alpha sub-unit isoforms in evolution
21. Phylogenetic conservation of isoform specific regions within a subunit of NaK-ATPase
22. Ligand binding sites of NaK-ATPase
23. The tolerance of children for digitalis
24. Comparison of the sensitivity of children and adults to digoxin
25. Digoxin 'receptors' in neonates: an explanation of less sensitivity to digoxin than in adults
26. 0.5 values in NaK-adenosine triphosphatase from different species
27. Comparative species studies on the effects of monovalent cation and ouabain on cardiac NaK-adenosine triphosphatase and contractile force
28. Effect of age on the cardiotoxic action of digitalis
29. The effect of age of cats on susceptibility to digitalis
30. Cardiac glycoside sensitivity of NaK-activated ATPase in newborn rats
31. Cardiac toxicity of digoxin in newborn and adult rats
32. Postnatal changes in NaK-ATPase isoform expression in rat cardiac ventricle: conservation of biphasic ouabain affinity
33. Influence of age on the sensitivity of the guinea pig and its myocardium to ouabain
34. Age dependence of myocardial NaK-ATPase activity and digitalis intoxication in the dog and guinea pig
35. Digitalis tolerance in young puppies
36. Comparison between puppies and adult dogs following infusion of digoxin
37. Differential effects of digoxin at comparable concentrations in tissues of fetal and adult sheep
38. Age-related effects of digoxin on myocardial contractility and Na-K pump in sheep
39. NaK-ATPase activity of embryonic chick heart and skeletal muscles as a function of age
40. Tissue-specific and developmental regulation of rat NaK-ATPase catalytic alpha isoform and beta sub-unit mRNAs
41. Random mutagenesis of the sheep NaK-ATPase alpha 1 sub-unit generating the ouabain-resistant mutant L793P
42. The therapeutic action of digitalis on the rapid, regular, rheumatic heart
43. Studies on the dosage of digitalis in children
44. Digitalis therapy in cardiac decompensation in children
45. Cardiac failure in children under five years of age with special reference to acute rheumatic myocarditis
46. Digitalis studies on children with heart disease: the effects of digitalis on the sinus rate of children with rheumatic fever and chronic valvular heart disease
47. Effects of digitalis on edema of children with rheumatic fever and chronic valvular disease in the presence of sinus rhythm
48. Treatment of congestive heart failure in children with active rheumatic fever
49. The use of digitalis in infants and children: a clinical study of patients with congestive heart failure
50. The use of digoxin in infants and children
51. Effects of digoxin on systolic time intervals of neonates and infants
52. Echocardiographic left ventricular function in infants with congestive heart failure
53. Effect of digoxin on left ventricular contractility in newborns and infants estimated by echocardiography
54. The left ventricular end systolic wall stress-velocity of fiber shortening relation: a load-independent index of myocardial contractility
55. Treatment of congestive heart failure by altering loading conditions of the heart
56. Commentary: a reappraisal of digitalis for infants with large left-to-right shunts and 'heart failure'
57. Reappraisal of digitalis in infants with left-to-right shunts and heart failure
58. Does digoxin have a place in the treatment of a child with congenital heart disease?
59. Congestive heart failure in infancy and childhood
60. Effects of digoxin in infants with a congested circulatory state due to a ventricular septal defect
61. Beta-blocker therapy of severe congestive heart failure in infants with left-to-right shunts
62. Mechanism of decreased forward stroke volume in children and swine with ventricular septal defect and failure to thrive
63. Hemodynamic correlates of clinical severity in isolated ventricular septal defect
64. Effect of digoxin on contractility and symptoms in infants with a large ventricular septal defect
65. Further evidence suggesting a limited role of digitalis in infants with circulatory congestion secondary to large ventricular septal defect
66. False elevation of apparent digoxin levels in plasma of premature infants
67. Endogenous substance in newborn infants causing false positive digoxin measurements
68. Digoxin-like immunoreactivity in premature and full-term infants not receiving digoxin therapy
69. A digoxin-like factor associates with erythrocyte sodium concentration, sodium transport, and ouabain binding
70. The influence of feeding regimens on endogenous digoxin-like immunoreactive substance concentration in infants
71. Inhibition of rat Na, K-ATPase isoforms by endogenous digitalis extracts from neonatal human plasma
72. Syva emit 2000 and Roche 'on line' subject to less interference by digoxin-like factors than Abbott TDx FPIA in newborns and pregnant women
73. Comparison of four digoxin immunoassays with respect to interference from digoxin-like immunoreactive factors
74. A new digoxin immunoassay substantially free of interference by digoxin immunoreactive factors
75. Endogenous cardiac glycosides
76. Digoxin intoxication in infants and children: correlation with serum levels
77. Complications associated with digoxin therapy in low birth weight infants
78. Acute pediatric digoxin ingestion: a ten-year experience
79. The use of digoxin-specific Fab fragments for severe digitalis intoxication in children